WO2006074379A3 - Methods and compositions involving esters of azelaic acid and other dicarboxylic acids - Google Patents
Methods and compositions involving esters of azelaic acid and other dicarboxylic acids Download PDFInfo
- Publication number
- WO2006074379A3 WO2006074379A3 PCT/US2006/000476 US2006000476W WO2006074379A3 WO 2006074379 A3 WO2006074379 A3 WO 2006074379A3 US 2006000476 W US2006000476 W US 2006000476W WO 2006074379 A3 WO2006074379 A3 WO 2006074379A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- azelaic acid
- carbon atoms
- alkyl
- esters
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to formulations of azelaic acid esters and other dicarboxylic acid esters, and their derivatives. In preferred embodiments, the esters have the general Formula (I) wherein R1 and R2 are selected from hydrogen, alkyl groups of up to about 18 carbon atoms and aryl groups of up to about 18 carbon atoms and alkylene group of up to about 18 carbon atoms and an arylene group of up to about 18 carbon atoms. The alkyl, aryl, alkylene and aryl groups may be substituted or unsubstituted, branched or straight chains. In addition, R1 and R2 may contain heteroatoms and may be straight chained or branched, n is an integer from 1-16, and R1 and R2 are not simultaneously hydrogen. R2OOC-(CH2)n-COOR1 (I). The azelaic acid derivatives of Formula (I) of this invention are certain derivatives of azelaic acid and other alkyl geminal diacids which possess a desirable high lipophilicity and biphasic solubility in comparison to the parent compound, azelaic acid, and which are cleaved enzymatically to azelaic acid. Compounds produced from the compounds of Formula (I) by the enzymatic hydrolysis of the R1 and R2 groups are useful as anti-bacterial agents in mammals in vivo and have been contemplated to be used in the treatment of skin disease.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64207505P | 2005-01-07 | 2005-01-07 | |
US60/642,075 | 2005-01-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006074379A2 WO2006074379A2 (en) | 2006-07-13 |
WO2006074379A3 true WO2006074379A3 (en) | 2007-04-12 |
Family
ID=36648220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/000476 WO2006074379A2 (en) | 2005-01-07 | 2006-01-06 | Methods and compositions involving esters of azelaic acid and other dicarboxylic acids |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006074379A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090326069A1 (en) * | 2008-06-30 | 2009-12-31 | Bltn, Llc | Azelaic acid ester compositions and methods for diagnosing and treating tissue conditions using azelaic acid ester compositions and proteinaceous biomarkers |
SI3445354T1 (en) | 2016-04-20 | 2022-10-28 | New Frontier Labs, Llc | Azelaic acid esters in the treatment of insulin resistance |
US20210269412A1 (en) * | 2018-06-23 | 2021-09-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory skin diseases and cancer |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4661519A (en) * | 1983-04-12 | 1987-04-28 | Pola Chemical Industries Inc. | Method for dermatological application |
FR2616430A1 (en) * | 1987-06-12 | 1988-12-16 | Oreal | New diesters of azelaic acid, process for preparing them, topical compositions containing them and their use in the treatment of acne |
US5637305A (en) * | 1994-09-08 | 1997-06-10 | Avantgarde S.P.A. | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
-
2006
- 2006-01-06 WO PCT/US2006/000476 patent/WO2006074379A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4661519A (en) * | 1983-04-12 | 1987-04-28 | Pola Chemical Industries Inc. | Method for dermatological application |
FR2616430A1 (en) * | 1987-06-12 | 1988-12-16 | Oreal | New diesters of azelaic acid, process for preparing them, topical compositions containing them and their use in the treatment of acne |
US5637305A (en) * | 1994-09-08 | 1997-06-10 | Avantgarde S.P.A. | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 198906, Derwent World Patents Index; AN 1989-041097, XP003009974 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006074379A2 (en) | 2006-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2565660A1 (en) | Ortho substituted aryl or heteroaryl amide compounds | |
DE60322889D1 (en) | FLUORATED PHOSPHONIC ACIDS | |
EA201190099A1 (en) | (1-PHENYL-2-PYRIDIN-4-IL) ETHYL ESTERS OF BENZOIC ACID AS PHYSHODESTERES INHIBITORS | |
RU2001102614A (en) | New acylated pseudodipeptides, method for their preparation and pharmaceutical compositions containing them | |
ATE506352T1 (en) | METHOD FOR PRODUCING OPTIONAL 2-SUBSTITUTED 1,6-DIHYDRO-6-OXO-4-PYRIMIDINCARBOXYLIC ACIDS | |
JP2006514610A (en) | Furanone derivative and method for producing the same | |
KR20150129004A (en) | Activity-based probe compounds, compositions, and methods of use | |
WO2009081152A3 (en) | Antimicrobial compounds | |
EP2088140B1 (en) | Dihydrazide compounds, preparation and uses thereof | |
ATE420847T1 (en) | SUBSTITUTED PHENYLALKANIC ACID DERIVATIVE AND USE THEREOF | |
FR2683223A1 (en) | (JP) AMPHIPHILE COMPOUNDS WITH DOUBLE HEAD SUGAR SURFACTANT AGENT AND VESICULAR AGENT COMPRISING SUCH A COMPOUND AND PROCESS FOR PREPARING THE SAME. | |
TN2009000276A1 (en) | PROCESS FOR THE MANUFACTURE OF 3-AMINO-TETRAHYDROFURANE-3-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS MEDICAMENTS | |
WO2006074379A3 (en) | Methods and compositions involving esters of azelaic acid and other dicarboxylic acids | |
ATE422200T1 (en) | METHOD FOR PRODUCING SUBSTITUTED NICOTINIC ACID ESTERS | |
WO2010007363A3 (en) | Preparation of fluorine-labelled compounds | |
EA201170057A1 (en) | METHOD FOR PRODUCING SUBSTITUTED 2-AMINOTHIAZOLONES | |
DE50212728D1 (en) | PROCESS FOR THE PREPARATION OF 2-AZETIDINONE DERIVATIVES | |
WO2003089577A3 (en) | Antihelminthic anthraquinones and method of use thereof | |
KR890014514A (en) | Compounds that inhibit the biosynthesis of lipoxygenase-induced metabolites of arachidonic acid | |
TW200628985A (en) | A chemically amplified positive resist composition | |
FR2900405B1 (en) | NOVEL MONOFLUORINE C-GLYCOSIDE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATIONS | |
ES2222822B1 (en) | DIAMIDES OF AMINO ACIDS IN NON-ALFA POSITION USEFUL AS ASSISTANTS FOR THE ADMINISTRATION OF ACTIVE BIOLOGICAL AGENTS. | |
US6602832B2 (en) | Oil-soluble additive compositions for lubricating oils | |
WO2003029228A1 (en) | Novel method of preparing nitrogen macrocycles | |
RU2012109572A (en) | N-SULPHATED OLIGOSACCHARIDES, ACTIVATING FGF RECEPTORS, THEIR PRODUCTION AND APPLICATION IN THERAPY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO COMMUNICATION FORM 1205A HAS BEEN SENT ON16-10-2007) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06717649 Country of ref document: EP Kind code of ref document: A2 |